Other blue chips under pressure included Marks & Spencer, Barclays and Rolls-Royce, with their shares down by around 0.5%.

Epitopea, a transatlantic cancer immunotherapeutics company developing accessible off-the-shelf RNA-based immunotherapies, announces the appointment of Dr. Klaus Edvardsen as its new Chief Medical ...